Left main PCI: Requiem for the Syntax score?

Original Title: Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity. Reference: JACC Cardiovascular Interventions. Doi: 10.1016/j.jcin.2016.02.016. Courtesy of Dr. Agustín Vecchia.   In patients with unprotected left main disease (ULMD) associated to complex coronary anatomy, choosing a revascularization strategy can be challenging. Current guidelines recommend surgery for<a href="https://solaci.org/en/2016/06/06/left-main-pci-requiem-for-the-syntax-score/" title="Read more" >...</a>

Left Main Disease angioplasty in patients with severe aortic stenosis Javier Ibáñez, MD

ISAR-LEFT MAIN 2: Everolimus-eluting stents versus Zotarolimus eluting stents in the treatment of the unprotected left coronary trunk.

Summary: Second-generation drug-eluting stents have shown better results than their predecessors. In this study we compare two second-generation drug stents in patients with unprotected left coronary trunk injuries. Methods and results: 650 patients with unprotected trunk injury were randomized to either XIENCE V (everolimus eluting) or RESOLUTE (zotarolimus eluting) stents. The primary endpoint was the<a href="https://solaci.org/en/2015/06/24/isar-left-main-2-everolimus-eluting-stents-versus-zotarolimus-eluting-stents-in-the-treatment-of-the-unprotected-left-coronary-trunk/" title="Read more" >...</a>

Left Main Disease Revascularization. The Position of New European and U.S. Guidelines and how it is Performed in Different Geographical Regions

Thomas Cuisset 2012-08-10

Single Antiplatelet Therapy Following Percutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion (LAAO) has surged as an effective alternative to treat patients with atrial fibrillation (AF) presenting counterindications for oral anticoagulants. However, the optimal antithrombotic treatment after LAAO is still debated, seeing as it should prevent device related thrombosis (DRT) while minimizing bleeding risk.  The aim of this retrospective study carried out<a href="https://solaci.org/en/2024/05/01/single-antiplatelet-therapy-following-percutaneous-left-atrial-appendage-occlusion/" title="Read more" >...</a>

TCT 2023 | SWISS-APERO: One-Year Events After Left Atrial Appendage Closure with Amulet or Watchman FLX Device

It has been observed that the persistence of an opening in the left atrial appendage after percutaneous closure (LAAC) is associated with a higher risk of embolic events. Among the most commonly used devices for left atrial appendage closure are the Watchman FLX and Amulet devices. This study, known as SwissApero, represents the first randomized<a href="https://solaci.org/en/2023/10/27/tct-2023-swiss-apero-one-year-events-after-left-atrial-appendage-closure-with-amulet-or-watchman-flx-device/" title="Read more" >...</a>

Left Atrial Appendage Occlusion: Clinical Outcomes according to Device Implantation Depth

Continuous improvement of left atrial appendage occlusion (LAAO) devices has had a positive impact on the safety and efficacy of this technique. However, device related thrombus formation (DRT) is still a major concern because of the associated increased risk of thromboembolic events. Approaching this complication calls for more intense antithrombotic treatments, which in turn involves<a href="https://solaci.org/en/2023/08/28/left-atrial-appendage-occlusion-clinical-outcomes-according-to-device-implantation-depth/" title="Read more" >...</a>

A New Alternative for the Treatment of Heart Failure: Left Atrial to Coronary Sinus Shunt with the APTURE Device

ALT FLOW device for left atrial to coronary sinus shunting in symptomatic heart failure patients. In the treatment of heart failure (HF), significant improvement in patient quality of life and prognosis has been achieved through appropriate medical treatment and, in some cases, the use of devices. However, in certain cases, satisfactory clinical improvement cannot be<a href="https://solaci.org/en/2023/07/04/a-new-alternative-for-the-treatment-of-heart-failure-left-atrial-to-coronary-sinus-shunt-with-the-apture-device/" title="Read more" >...</a>

El cierre de orejuela es seguro con los nuevos dispositivos

Intracardiac Echocardiography to Guide Watchman Left Atrial Appendix Closure: Safe and Effective?

Left atrial appendix closure (LAAC) has become a frequent intervention for stroke prevention in patients with atrial fibrillation (AF) that make poor candidates for anticoagulation. However, it presents a complication with negative impact on procedural outcomes which is peridevice leak.  To reduce these complications, we use intra-procedural imaging, the transesophageal echocardiogram (TEE) being the most<a href="https://solaci.org/en/2023/03/02/intracardiac-echocardiography-to-guide-watchman-left-atrial-appendix-closure-safe-and-effective/" title="Read more" >...</a>

Do Men and Women Present the Same Evolution after Left Atrial Appendage Closure?

Atrial fibrillation is a very frequent type of arrythmia that affects both men and women alike. This entity is associated to higher mortality seeing as it favors stroke and hospitalization for cardiac failure.  At present, one of its valid treatment strategies is left atrial appendage closure, to reduce or prevent stroke and anticoagulation driven bleeding. <a href="https://solaci.org/en/2022/11/14/do-men-and-women-present-the-same-evolution-after-left-atrial-appendage-closure/" title="Read more" >...</a>